Skip to content

Clinical trials

Pulmonary Fibrosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Country / region: Australia Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20111
20131
20151
20171
20191
20202
20212
20222
20235
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting5
Terminated5
Recruiting4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Boehringer Ingelheim3
Endeavor Biomedicines, Inc.3
Celgene2
Kyntra Bio2
University of Sydney2
Amgen1
Avalyn Pharma Inc.1
Contineum Therapeutics1
Erasmus Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis26
Idiopathic Pulmonary Fibrosis13
Lung Diseases, Interstitial9
Idiopathic Interstitial Pneumonias4
Fibrosis2
Alveolitis, Extrinsic Allergic1
Arthritis, Rheumatoid1
Chronic Disease1
Connective Tissue Diseases1
Dyskeratosis Congenita1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.